Show simple item record

AuthorUrbańczyk, Kamila
AuthorGuntschnig, Sonja
AuthorAntoniadis, Vasilis
AuthorFalamic, Slaven
AuthorKovacevic, Tijana
AuthorKurczewska-Michalak, Marta
AuthorMiljković, Branislava
AuthorOlearova, Anna
AuthorSviestina, Inese
AuthorSzucs, Attila
AuthorTachkov, Konstantin
AuthorTiszai, Zita
AuthorVolmer, Daisy
AuthorWiela-Hojeńska, Anna
AuthorFialova, Daniela
AuthorVlcek, Jiri
AuthorStuhec, Matej
AuthorHogg, Anita
AuthorScott, Michael
AuthorStewart, Derek
AuthorMair, Alpana
AuthorRavera, Silvia
AuthorLery, François Xavier
AuthorKardas, Przemysław
Available date2023-08-29T05:30:26Z
Publication Date2023-01-01
Publication NameFrontiers in Pharmacology
Identifierhttp://dx.doi.org/10.3389/fphar.2023.1244151
CitationUrbańczyk K, Guntschnig S, Antoniadis V, Falamic S, Kovacevic T, Kurczewska-Michalak M, Miljković B, Olearova A, Sviestina I, Szucs A, Tachkov K, Tiszai Z, Volmer D, Wiela-Hojeńska A, Fialova D, Vlcek J, Stuhec M, Hogg A, Scott M, Stewart D, Mair A, Ravera S, Lery F-X and Kardas P (2023) Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Front. Pharmacol. 14:1244151. doi: 10.3389/fphar.2023.1244151
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85168282722&origin=inward
URIhttp://hdl.handle.net/10576/46878
AbstractClinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
Languageen
PublisherFrontiers Media
Subjectclinical pharmacy
cost-effective treatment
drug safety
drug utilization
health policy
medication adherence
medication errors
polypharmacy
TitleRecommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
TypeArticle
Volume Number14
ESSN1663-9812
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record